riTUXimab-arrx 500 MG in 50 ML Injection
- RxCUI
- 2472335
- RxNorm name
- riTUXimab-arrx 500 MG in 50 ML Injection
- Display name
- riTUXimab-arrx 500 MG in 50 ML Injection
- Full name
- riTUXimab-arrx 500 MG in 50 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761140 | Riabni | rituximab-arrx | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Riabni | RITUXIMAB-ARRX | Amgen, Inc | da1c4de7-0e5b-4f72-97ec-7a8d368f085f | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 2472335 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| da1c4de7-0e5b-4f72-97ec-7a8d368f085f | riTUXimab-arrx 500 MG in 50 ML Injection [PSN] · 50 ML rituximab-arrx 10 MG/ML Injection [SCD] · rituximab-arrx 500 MG per 50 ML Injection [SY] | 3 | 9 | These highlights do not include all the information needed to use RIABNI safely and effectively. See full prescribing information for RIABNI. RIABNI ® (rituximab-arrx) injection, for intravenous use Initial U.S. Approval: 2020 RIABNI (rituximab-arrx) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the | 20250912 |